Vaxxinity | 8-K: Current report
Apr 19 16:11 ET
Vaxxinity | 10-K: Annual report
Mar 27 16:20 ET
Vaxxinity | 8-K: Current report
Mar 14 16:25 ET
Vaxxinity | 8-K: Current report
Feb 15 16:19 ET
Vaxxinity | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mei Mei Hu(70.5%)
Feb 12 17:06 ET
Vaxxinity | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lou Reese(9.4%)
Feb 12 17:06 ET
Vaxxinity | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Prime Movers Lab Fund I LP(1.06%),Prime Movers Lab GP I LLC(1.06%), etc.
Feb 7 16:38 ET
Vaxxinity | 144: Notice of proposed sale of securities pursuant to Rule 144
Jan 30 16:08 ET
Vaxxinity | 8-K: Current report
Dec 1, 2023 10:30 ET
Vaxxinity | 144: Notice of proposed sale of securities pursuant to Rule 144
Nov 30, 2023 17:03 ET
Vaxxinity | 144: Notice of proposed sale of securities pursuant to Rule 144
Nov 30, 2023 16:54 ET
Vaxxinity | 144: Notice of proposed sale of securities pursuant to Rule 144
Nov 29, 2023 17:13 ET
Vaxxinity | 144: Notice of proposed sale of securities pursuant to Rule 144
Nov 29, 2023 17:10 ET
Vaxxinity | 144: Notice of proposed sale of securities pursuant to Rule 144
Nov 21, 2023 16:21 ET
Vaxxinity | 144: Notice of proposed sale of securities pursuant to Rule 144
Nov 21, 2023 16:20 ET
Vaxxinity: Q3 2023 Earnings Report
Nov 8, 2023 07:53 ET
Vaxxinity | 4: Statement of changes in beneficial ownership of securities-Officer Paula Molina Rene
Nov 3, 2023 16:31 ET
Vaxxinity | 4: Statement of changes in beneficial ownership of securities-Director Powchik Peter
Oct 11, 2023 21:42 ET
Vaxxinity | 3: Initial statement of beneficial ownership of securities-Officer Ray Sumita
Oct 11, 2023 21:40 ET
Vaxxinity | 144: Notice of proposed sale of securities pursuant to Rule 144
Oct 4, 2023 16:33 ET
No Data
No Data